Complete Filing Data
Nautilus Biotechnology, Inc. reported Stockholders Equity of $156.97 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Nautilus Biotechnology, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income Loss | -$59.0M | -$70.8M | -$63.7M | -$57.9M | -$50.3M | -$15.6M |
| General And Administrative Expense | $25.7M | $31.0M | $28.9M | $25.9M | $21.1M | $3.3M |
| Research And Development Expense | $41.1M | $50.5M | $47.3M | $37.7M | $29.4M | $12.4M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $186.0K | $312.0K | $1.6M | -$1.7M | -$187.0K | -$4.0K |
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | $186.0K | $312.0K | $1.6M | -$1.7M | -$187.0K | -$4.0K |
| Operating Expenses | $66.8M | $81.5M | $76.2M | $63.6M | $50.5M | $15.7M |
| Nonoperating Income Expense | $7.8M | $10.7M | $12.5M | $5.7M | $183.0K | $125.0K |
| Comprehensive Income Net Of Tax | -$58.8M | -$70.5M | -$62.1M | -$59.6M | -$50.5M | -$15.6M |
| Interest Income Expense Nonoperating Net | $7.9M | $10.8M | $12.6M | $5.8M | $329.0K | |
| Other Nonoperating Expense | $32.0K | $84.0K | $73.0K | $122.0K | $146.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$13.6M | -$15.0M | -$16.6M | -$16.4M | -$18.0M | -$18.7M | -$15.9M | -$15.8M | -$15.0M | -$14.1M | -$14.7M | -$15.8M | -$14.5M | -$10.7M | -$8.4M | -$4.0M | -$3.4M | $0.00 |
| General And Administrative Expense | $5.9M | $6.7M | $7.3M | $6.8M | $8.4M | $8.7M | $7.1M | $7.1M | $7.2M | $6.2M | $6.6M | $6.4M | $6.3M | $4.3M | $3.6M | $710.0K | $649.0K | |
| Research And Development Expense | $9.6M | $10.4M | $11.5M | $12.3M | $12.4M | $12.9M | $12.0M | $11.9M | $10.9M | $9.6M | $8.9M | $9.7M | $8.2M | $6.4M | $4.8M | $3.3M | $2.8M | |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $123.0K | -$112.0K | $132.0K | $1.3M | $199.0K | -$490.0K | $356.0K | -$1.4M | $895.0K | -$1.1M | -$214.0K | -$370.0K | $1.0K | -$12.0K | -$1.0K | $0.00 | -$25.0K | |
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | $123.0K | -$112.0K | $132.0K | $1.3M | $199.0K | -$490.0K | $356.0K | -$1.4M | $895.0K | -$1.1M | -$214.0K | -$370.0K | $1.0K | -$12.0K | -$1.0K | $0.00 | -$25.0K | |
| Operating Expenses | $15.5M | $17.1M | $18.8M | $19.1M | $20.8M | $21.6M | $19.1M | $19.0M | $18.1M | $15.8M | $15.5M | $16.0M | $14.6M | $10.7M | $8.4M | $4.0M | $3.4M | |
| Nonoperating Income Expense | $1.9M | $2.1M | $2.2M | $2.7M | $2.8M | $2.9M | $3.2M | $3.2M | $3.1M | $1.8M | $783.0K | $259.0K | $64.0K | -$16.0K | $8.0K | $49.0K | $45.0K | |
| Comprehensive Income Net Of Tax | -$13.5M | -$15.1M | -$16.5M | -$15.2M | -$17.8M | -$19.2M | -$15.5M | -$17.2M | -$14.1M | -$15.2M | -$14.9M | -$16.1M | -$14.5M | -$10.7M | -$8.4M | -$4.0M | -$3.4M | |
| Interest Income Expense Nonoperating Net | $1.9M | $2.1M | $2.2M | $2.7M | $2.8M | $2.9M | $3.2M | $3.2M | $3.1M | $1.9M | $776.0K | $264.0K | ||||||
| Other Nonoperating Expense | $5.0K | $16.0K | $20.0K | $19.0K | $0.00 | $0.00 | $14.0K | $3.0K | $5.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $157.0M | $208.7M | $265.4M | $314.9M | $363.6M | -$29.7M | -$14.5M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $13.4M | $28.6M | $20.4M | $115.5M | $186.5M | $37.2M | $595.0K |
| Retained Earnings Accumulated Deficit | -$332.0M | -$273.0M | -$202.2M | -$138.6M | -$80.6M | -$30.3M | |
| Liabilities Current | $8.0M | $7.6M | $9.1M | $6.8M | $5.8M | $3.0M | |
| Liabilities And Stockholders Equity | $191.1M | $242.7M | $305.6M | $350.1M | $398.5M | $85.0M | |
| Assets | $191.1M | $242.7M | $305.6M | $350.1M | $398.5M | $85.0M | |
| Liabilities | $34.1M | $34.0M | $40.2M | $35.1M | $34.9M | $6.3M | |
| Assets Current | $106.0M | $132.8M | $176.8M | $187.2M | $349.2M | $77.7M | |
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Accounts Payable Current | $943.0K | $987.0K | $1.6M | $1.3M | $1.7M | $470.0K | |
| Operating Lease Right Of Use Asset Amortization Expense | $4.7M | $4.4M | $3.9M | $2.2M | $1.8M | $1.6M | |
| Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 | $99.0K | $74.0K | $148.0K | $174.0K | $64.0K | $67.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$15.3M | $8.2M | -$95.1M | -$71.0M | $149.2M | $36.6M | |
| Accretion Amortization Of Discounts And Premiums Investments | $1.4M | $2.8M | $2.7M | $890.0K | -$183.0K | -$282.0K | |
| Property Plant And Equipment Net | $3.5M | $4.1M | $4.3M | $3.7M | $2.5M | $1.4M | |
| Prepaid Expense And Other Assets Current | $2.6M | $2.9M | $3.4M | $2.7M | $3.5M | $917.0K | |
| Other Assets Noncurrent | $1.2M | $1.2M | $1.2M | $1.1M | $997.0K | $1.1M | |
| Operating Lease Right Of Use Asset | $27.8M | $28.3M | $32.6M | $28.9M | $29.4M | $4.8M | |
| Operating Lease Liability Noncurrent | $26.2M | $26.4M | $31.1M | $28.3M | $29.1M | $3.3M | |
| Operating Lease Liability Current | $3.8M | $4.1M | $3.5M | $2.0M | $970.0K | $1.5M | |
| Common Stock Value | $13.0K | $13.0K | $13.0K | $12.0K | $12.0K | $1.0K | |
| Cash And Cash Equivalents At Carrying Value | $12.4M | $27.6M | $19.4M | $114.5M | $185.6M | $36.6M | |
| Available For Sale Securities Debt Securities Current | $91.0M | $102.2M | $154.0M | $69.9M | $160.1M | $40.1M | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | $243.0K | $57.0K | -$255.0K | -$1.9M | -$184.0K | $3.0K | |
| Accrued Liabilities And Other Liabilities Current | $3.2M | $2.5M | $3.9M | $3.5M | $3.1M | $1.1M | |
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $0.00 | $7.6M | $1.7M | $29.9M | $0.00 | ||
| Long Term Investments | $16.4M | $0.00 | |||||
| Modification To Reduce Right Of Use Assets And Lease Liability | $0.00 | $3.5M | $0.00 | ||||
| Available For Sale Securities Debt Securities Noncurrent | $52.7M | $76.4M | $90.6M | $129.2M | |||
| Deferred Stock Issuance Costs Reclassified To Equity | $0.00 | $8.1M | $0.00 | ||||
| Deferred Stock Issuance Costs | $0.00 | $212.0K | |||||
| Deferred Underwriting Fee Payable Non Current | |||||||
| Temporary Equity Carrying Amount Attributable To Parent |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $169.1M | $181.1M | $194.4M | $223.4M | $235.3M | $249.5M | $277.3M | $289.7M | $303.7M | $325.3M | $337.6M | $349.7M | $377.8M | $390.0M | -$36.8M | -$24.6M | -$20.7M | -$17.4M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $24.9M | $35.5M | $34.2M | $5.4M | $25.9M | $26.7M | $75.1M | $73.8M | $89.5M | $189.8M | $211.2M | $189.5M | $190.9M | $289.0M | $52.4M | $13.2M | $32.9M | |||
| Retained Earnings Accumulated Deficit | -$318.2M | -$304.7M | -$289.6M | -$255.4M | -$239.0M | -$221.0M | -$185.2M | -$169.3M | -$153.5M | -$125.2M | -$111.1M | -$96.4M | -$64.0M | -$49.4M | -$2.3M | -$170.7K | -$11.7K | |||
| Liabilities Current | $9.0M | $8.1M | $8.2M | $8.7M | $8.7M | $9.2M | $8.9M | $7.9M | $7.9M | $6.4M | $6.1M | $6.4M | $4.2M | $3.2M | $1.8M | $128.7K | $198.0K | |||
| Liabilities And Stockholders Equity | $200.9M | $213.2M | $227.7M | $259.7M | $272.7M | $288.7M | $318.3M | $330.8M | $345.9M | $359.3M | $371.7M | $384.7M | $385.3M | $393.3M | $150.5M | $151.0M | $211.3K | |||
| Assets | $200.9M | $213.2M | $227.7M | $259.7M | $272.7M | $288.7M | $318.3M | $330.8M | $345.9M | $359.3M | $371.7M | $384.7M | $385.3M | $393.3M | $150.5M | $151.0M | $211.3K | |||
| Liabilities | $31.8M | $32.1M | $33.3M | $36.3M | $37.5M | $39.2M | $41.1M | $41.1M | $42.2M | $34.0M | $34.1M | $35.0M | $7.5M | $3.2M | $7.0M | $5.4M | ||||
| Assets Current | $134.3M | $150.7M | $141.6M | $144.2M | $170.9M | $185.1M | $186.8M | $166.7M | $170.5M | $261.2M | $303.4M | $327.1M | $352.2M | $374.6M | $935.6K | $1.4M | ||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Accounts Payable Current | $893.0K | $974.0K | $841.0K | $1.5M | $1.6M | $1.9M | $1.1M | $1.2M | $1.3M | $823.0K | $1.4M | $1.5M | $1.5M | $1.2M | $116.8K | $6.1K | $9.6K | |||
| Operating Lease Right Of Use Asset Amortization Expense | $1.2M | $1.1M | $786.0K | $525.0K | $413.0K | |||||||||||||||
| Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 | $59.0K | $275.0K | $115.0K | $222.0K | $142.0K | |||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $5.6M | $6.3M | -$26.0M | $3.0M | $15.2M | |||||||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $541.0K | $751.0K | $669.0K | -$26.0K | -$115.0K | |||||||||||||||
| Property Plant And Equipment Net | $3.6M | $3.7M | $3.8M | $4.3M | $4.7M | $4.5M | $4.3M | $4.2M | $3.9M | $3.7M | $3.4M | $2.8M | $2.0M | $1.9M | ||||||
| Prepaid Expense And Other Assets Current | $2.9M | $2.9M | $2.8M | $3.6M | $3.5M | $3.7M | $3.5M | $3.4M | $3.1M | $3.3M | $4.1M | $2.9M | $4.9M | $1.5M | ||||||
| Other Assets Noncurrent | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.8M | $1.1M | $997.0K | $997.0K | $997.0K | $767.0K | $612.0K | ||||||
| Operating Lease Right Of Use Asset | $24.7M | $25.9M | $27.1M | $29.4M | $30.5M | $31.6M | $33.7M | $34.7M | $35.7M | $27.8M | $28.3M | $28.9M | $3.7M | $828.0K | ||||||
| Operating Lease Liability Noncurrent | $22.8M | $24.0M | $25.1M | $27.6M | $28.8M | $29.9M | $32.2M | $33.2M | $34.2M | $27.5M | $28.1M | $28.6M | $3.3M | $0.00 | ||||||
| Operating Lease Liability Current | $4.2M | $4.2M | $4.2M | $4.0M | $3.8M | $3.7M | $3.5M | $3.3M | $3.1M | $1.6M | $1.6M | $1.5M | $314.0K | $686.0K | ||||||
| Common Stock Value | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | ||||||
| Cash And Cash Equivalents At Carrying Value | $23.9M | $34.5M | $33.2M | $4.4M | $24.9M | $25.7M | $74.1M | $72.1M | $88.5M | $188.9M | $210.4M | $188.6M | $190.2M | $288.4M | ||||||
| Available For Sale Securities Debt Securities Current | $107.6M | $113.4M | $105.6M | $136.2M | $142.6M | $155.6M | $109.2M | $91.2M | $78.8M | $69.0M | $89.0M | $135.5M | $157.1M | $84.8M | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $200.0K | $77.0K | $189.0K | $731.0K | -$546.0K | -$745.0K | -$2.0M | -$2.4M | -$959.0K | -$1.9M | -$768.0K | -$554.0K | -$9.0K | -$10.0K | ||||||
| Accrued Liabilities And Other Liabilities Current | $3.9M | $2.9M | $3.1M | $3.2M | $3.2M | $3.7M | $4.3M | $3.4M | $3.6M | $4.0M | $3.1M | $3.4M | $2.4M | $1.3M | ||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $0.00 | $7.6M | $0.00 | |||||||||||||||||
| Long Term Investments | $92.4M | $123.4M | $134.6M | $129.2M | $65.7M | $35.6M | $24.9M | $26.6M | $15.3M | |||||||||||
| Modification To Reduce Right Of Use Assets And Lease Liability | $0.00 | $3.3M | ||||||||||||||||||
| Available For Sale Securities Debt Securities Noncurrent | $37.1M | $31.6M | $54.0M | $80.6M | $65.5M | $66.3M | ||||||||||||||
| Deferred Stock Issuance Costs Reclassified To Equity | ||||||||||||||||||||
| Deferred Stock Issuance Costs | $0.00 | $1.1M | ||||||||||||||||||
| Deferred Underwriting Fee Payable Non Current | $5.2M | $5.2M | $5.2M | |||||||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | $138.5M | $140.2M | $140.6M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$50.7M | -$59.1M | -$51.7M | -$45.8M | -$39.2M | -$14.0M |
| Net Cash Provided By Used In Investing Activities | $35.2M | $66.3M | -$43.7M | -$25.7M | -$139.0M | -$25.3M |
| Net Cash Provided By Used In Financing Activities | $214.0K | $1.1M | $368.0K | $562.0K | $327.4M | $75.9M |
| Increase Decrease In Accounts Payable | -$69.0K | -$578.0K | $393.0K | -$561.0K | $1.3M | $123.0K |
| Increase Decrease In Operating Lease Liability | $4.2M | -$4.2M | -$3.2M | -$1.4M | -$788.0K | -$1.6M |
| Share Based Compensation | $6.8M | $12.7M | $12.1M | $10.4M | $7.9M | $369.0K |
| Proceeds From Sale And Maturity Of Available For Sale Securities | $109.0M | $155.4M | $71.6M | $163.2M | $85.1M | $44.0M |
| Payments To Acquire Property Plant And Equipment | $1.3M | $2.1M | $2.4M | $2.3M | $2.3M | $921.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$544.0K | -$666.0K | $821.0K | -$756.0K | $2.8M | $624.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $629.0K | -$1.4M | $417.0K | $409.0K | $2.3M | $695.0K |
| Proceeds From Stock Options Exercised | $58.0K | $620.0K | $104.0K | $330.0K | $167.0K | $42.0K |
| Payments To Acquire Available For Sale Securities Debt | $72.5M | $86.3M | $112.9M | $186.6M | $221.8M | $68.4M |
| Proceeds From Stock Plans | $156.0K | $524.0K | $264.0K | $232.0K | $0.00 | |
| Payments Of Stock Issuance Costs | $0.00 | $8.1M | $0.00 | |||
| Proceeds From Reverse Recapitalization Transaction | $0.00 | $335.4M | $0.00 | |||
| Proceeds From Issuance Of Redeemable Convertible Preferred Stock | $0.00 | $75.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q2 2020 |
|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$13.9M | -$16.3M | -$12.5M | -$12.3M | -$6.3M | $0.00 |
| Net Cash Provided By Used In Investing Activities | $19.5M | $22.4M | -$13.5M | $15.2M | $23.5M | |
| Net Cash Provided By Used In Financing Activities | $18.0K | $245.0K | $1.0K | $156.0K | -$2.1M | |
| Increase Decrease In Accounts Payable | -$131.0K | $94.0K | $53.0K | -$394.0K | $724.0K | |
| Increase Decrease In Operating Lease Liability | -$1.1M | -$1.0M | -$526.0K | $18.0K | -$246.0K | |
| Share Based Compensation | $2.2M | $3.1M | $2.9M | $2.1M | $1.3M | |
| Proceeds From Sale And Maturity Of Available For Sale Securities | $26.6M | $23.0M | $14.2M | $38.6M | $24.0M | |
| Payments To Acquire Property Plant And Equipment | $219.0K | $647.0K | $692.0K | $481.0K | $482.0K | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$167.0K | $309.0K | $513.0K | -$554.0K | $391.0K | |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $525.0K | -$268.0K | $65.0K | $308.0K | -$9.0K | |
| Proceeds From Stock Options Exercised | $18.0K | $245.0K | $1.0K | $156.0K | $0.00 | |
| Payments To Acquire Available For Sale Securities Debt | $6.9M | $0.00 | $27.1M | $22.9M | $0.00 | |
| Proceeds From Stock Plans | ||||||
| Payments Of Stock Issuance Costs | $0.00 | $2.1M | ||||
| Proceeds From Reverse Recapitalization Transaction | ||||||
| Proceeds From Issuance Of Redeemable Convertible Preferred Stock |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.47 | -$0.56 | -$0.51 | -$0.46 | -$0.60 | -$0.54 |
| Weighted Average Number Of Shares Outstanding Basic | 126.3M | 125.4M | 124.9M | 124.6M | 84.5M | 29.1M |
| Weighted Average Number Of Diluted Shares Outstanding | 126.3M | 125.4M | 124.9M | 124.6M | 84.5M | 29.1M |
| Earnings Per Share Basic | $-0.47 | $-0.56 | $-0.51 | $-0.46 | $-0.60 | $-0.54 |
| Common Stock Shares Outstanding | 126.5M | 126.1M | 125.1M | 124.9M | 124.3M | 33.1M |
| Common Stock Shares Authorized | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 98.7M |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 0.00 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Issued | 126.5M | 126.1M | 125.1M | 124.9M | 124.3M | 33.1M |
| Temporary Equity Shares Outstanding | 0.00 | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.11 | -$0.12 | -$0.13 | -$0.13 | -$0.14 | -$0.15 | -$0.13 | -$0.13 | -$0.12 | -$0.11 | -$0.12 | -$0.13 | -$0.12 | -$0.19 | -$0.25 | -$0.13 | -$0.12 | |
| Weighted Average Number Of Shares Outstanding Basic | 126.3M | 126.2M | 126.1M | 125.5M | 125.3M | 125.1M | 124.9M | 124.6M | 124.6M | 124.7M | 124.5M | 124.4M | 124.1M | 55.1M | 33.0M | 30.0M | 28.2M | |
| Weighted Average Number Of Diluted Shares Outstanding | 126.3M | 126.2M | 126.1M | 125.5M | 125.3M | 125.1M | 124.9M | 124.6M | 124.6M | 124.7M | 124.5M | 124.4M | 124.1M | 55.1M | 33.0M | 30.0M | 28.2M | |
| Earnings Per Share Basic | $-0.11 | $-0.12 | $-0.13 | $-0.13 | $-0.14 | $-0.15 | $-0.13 | $-0.13 | $-0.12 | $-0.11 | $-0.12 | $-0.13 | $-0.12 | $-0.19 | $-0.25 | $-0.13 | $-0.12 | |
| Common Stock Shares Outstanding | 126.3M | 126.3M | 126.1M | 125.6M | 125.4M | 125.3M | 124.9M | 124.9M | 124.9M | 124.7M | 124.6M | 124.5M | 124.2M | 124.1M | ||||
| Common Stock Shares Authorized | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | ||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 200.0M | 200.0M | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 200.0M | 200.0M | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 1.0M | 1.0M | 1.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Issued | 126.3M | 126.3M | 126.1M | 125.6M | 125.4M | 125.3M | 124.9M | 124.9M | 124.9M | 124.7M | 124.6M | 124.5M | 124.2M | 124.1M | ||||
| Temporary Equity Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $6.8M | $12.7M | $12.1M | $10.4M | $7.9M | $369.0K |
| Depreciation | $2.0M | $1.8M | $1.2M | $1.0M | $710.0K | |
| Stock Issued During Period Value Stock Options Exercised | $58.0K | $620.0K | $104.0K | $330.0K | $167.0K | $42.0K |
| Additional Paid In Capital | $488.7M | $481.7M | $467.8M | $455.3M | $444.4M | $600.0K |
| Stock Issued During Period Value Employee Stock Purchase Plan | $156.0K | $524.0K | $264.0K | $232.0K | ||
| Stock Issued During Period Shares Stock Options Exercised | 112.1K | 790.1K | 70.9K | 463.2K | 273.7K | 137.3K |
| Stock Issued During Period Value Reverse Recapitalization | $327.3M | |||||
| Conversion Of Stock Amount Converted1 | $0.00 | $108.4M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.5M | $1.7M | $2.2M | $3.2M | $3.3M | $3.1M | $3.1M | $3.1M | $2.9M | $2.9M | $2.6M | $2.1M | $2.2M | $1.8M | $1.3M | $59.0K | $41.0K |
| Depreciation | $400.0K | $400.0K | $465.0K | $500.0K | $500.0K | $516.0K | $500.0K | $400.0K | $385.0K | $300.0K | $300.0K | $281.0K | $300.0K | $300.0K | $214.0K | $200.0K | $200.0K |
| Stock Issued During Period Value Stock Options Exercised | $8.0K | $18.0K | $140.0K | $30.0K | $245.0K | $16.0K | $6.0K | $1.0K | $86.0K | $32.0K | $156.0K | $58.0K | $46.0K | $28.0K | $4.0K | ||
| Additional Paid In Capital | $487.2M | $485.7M | $483.9M | $478.1M | $474.8M | $471.2M | $464.5M | $461.4M | $458.2M | $452.4M | $449.4M | $446.7M | $441.8M | $439.5M | $7.3M | $5.2M | $24.6K |
| Stock Issued During Period Value Employee Stock Purchase Plan | $87.0K | $289.0K | $92.0K | $153.0K | |||||||||||||
| Stock Issued During Period Shares Stock Options Exercised | 42.3K | 196.4K | 907.00 | 153.6K | |||||||||||||
| Stock Issued During Period Value Reverse Recapitalization | $327.3M | ||||||||||||||||
| Conversion Of Stock Amount Converted1 |
Most recent annual filing with the SEC: February 26, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.